Advertisement

Topics

Hyperion Adjusters Limited Company Profile

08:02 EST 13th December 2018 | BioPortfolio

Hyperion Adjusters Limited is a City based practice which commenced trading on May 1, 2003 and is owned by both the staff and an investor. The firm is primarily drawn from those professional and support staff who were formerly employed as the Entertainment & Contingency team at Crawford & Company. Our strength is the depth of expertise we possess across broad product lines in the areas of Contingency, Entertainment & Specie Risks.We constantly work towards absolute efficiency and delivery of a consistent quality service to our Clients.

We aim to be innovative in the range of services offered to our customers and provide solutions to their claim and risk management needs.

Location

64 Queen Street
London
London
EC4R 1AD
United Kingdom

Contact

Phone: 44 (0)20 7236 8888
Fax: 44 (0)207236 8898
Email: info@hyperionadjusters.com


News Articles [40 Associated News Articles listed on BioPortfolio]

Hyperion's blockchain-based distributed mapping system aims to revolutionize how maps are made ...

SINGAPORE, Aug. 19, 2018 /PRNewswire/ -- Hyperion, an open blockchain-based mapping architecture, has ambitious plans to fundamentally transform how maps are made - and how Read more...

One Year after Hurricane Irma, Public Adjusters Move Up to 20% for Damage

NAPLES, Fla., Sept. 7, 2018 /PRNewswire/ -- Homeowners in Florida now have less than 72 hours to file a home insurance claim and use a Read more...

Global MultiWalled Carbon Nanotubes Market Status and Outlook 20182025 [Report Updated: 02082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Water Treatment Chemicals Market: Analysis By Type Corrosion Inhibitors, Oxidizers Biocides, Scale Inhibitors, pH Adjusters, Coagulants, By EndUser, By Region, By Country 2018 Edition: Opportunities and Forecast 20132023 By EndUser Municipal, Pape

Executive SummaryA comprehensive research report created through extensive primary research inputs from industry experts, companies, stakeholders and secondary research, the report aims to present the...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously annou...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction

The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and clinical outcome data on ...

The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy

Hyperion Is A Prospective, Multicenter, Non-Interventional, Two-Cohort Study Collecting Primary Data In Patients With Locally Advanced Or Metastatic NSCLC Of Squamous Or Non-Squamous Histo...

Companies [91 Associated Companies listed on BioPortfolio]

Hyperion Adjusters Limited

Hyperion Adjusters Limited is a City based practice which commenced trading on May 1, 2003 and is owned by both the staff and an investor. The firm is primarily drawn from those professional and suppo...

Hyperion Therapeutics, Inc.

Hyperion Therapeutics is a privately held pharmaceutical company focused on the development of therapies that address critical unmet needs and underserved patient populations in t...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Hyperion Adjusters Limited" on BioPortfolio

We have published hundreds of Hyperion Adjusters Limited news stories on BioPortfolio along with dozens of Hyperion Adjusters Limited Clinical Trials and PubMed Articles about Hyperion Adjusters Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hyperion Adjusters Limited Companies in our database. You can also find out about relevant Hyperion Adjusters Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record